Semaglutide

Semaglutide is a prescription GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is available in oral tablets and subcutaneous injection formulations. Semaglutide provides effective long-term metabolic management when used alongside a healthy diet and regular physical activity.

BUY NOW

Category

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. It is widely prescribed for the management of type 2 diabetes and selected chronic weight management programs, with formulations available for daily oral administration or once-weekly subcutaneous injection. Manufactured under stringent pharmaceutical quality standards, semaglutide products are supplied as oral tablets and sterile prefilled injection pens to ensure reliable therapeutic performance. Semaglutide should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Semaglutide
Therapeutic Class GLP-1 Receptor Agonist
Available Dosage Forms Oral Tablets, Sterile Prefilled Injection Pens
Route of Administration Oral / Subcutaneous Injection
Indications Type 2 Diabetes Mellitus, Chronic Weight Management (Product Dependent)
Storage As Per Product Label

Product Also Known As

Semaglutide, GLP-1 Receptor Agonist, Oral Semaglutide, Semaglutide Injection, Semaglutide Pen, Weekly Semaglutide, Antidiabetic GLP-1 Therapy